Vascular Biogenics Ltd. (VBLT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1125499,
    "name": "Vascular Biogenics Ltd.",
    "stock_name": "Vascular Biogenics Ltd.",
    "full_name": "Vascular Biogenics Ltd.",
    "name_url": "stocks-analysis/vascular-biogenics",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.00",
    "mcapval": "0.00",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "IL0011327454",
    "curr_date": "Jun 30",
    "curr_time": "",
    "bse_nse_vol": "2 ",
    "exc_status": "Active",
    "traded_date": "Jun 30, 2025",
    "traded_date_str": "2025 06 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vascular-biogenics-1125499-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Vascular Biogenics Ltd. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-vascular-biogenics-ltd-technically-bullish-or-bearish-3546854",
        "imagepath": "",
        "date": "2025-09-20 19:41:51",
        "description": "As of 16 December 2024, the technical trend for Vascular Biogenics Ltd. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD also shows mild bullishness. However, the daily moving averages are mildly bearish, and the KST is bearish on both weekly and monthly time frames. The Bollinger Bands are sideways weekly but mildly bearish monthly, and there is no trend indicated by Dow Theory or OBV.\n\nThe company has significantly underperformed compared to the S&P 500, with a year-to-date return of -99.64% versus the S&P 500's 12.22%, and a one-year return of -99.98% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bearish, driven by mixed signals across various indicators...."
      },
      {
        "title": "Is Vascular Biogenics Ltd. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-vascular-biogenics-ltd-overvalued-or-undervalued-3543346",
        "imagepath": "",
        "date": "2025-09-20 18:16:59",
        "description": "As of 28 March 2019, the valuation grade for Vascular Biogenics Ltd. moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company appears to be overvalued given its current financial metrics, including a P/E ratio of -0.0001 and an EV to EBITDA of 0.28, which are both indicative of severe financial distress. Additionally, the negative ROE of -170.61% further underscores the challenges the company faces.\n\nIn comparison to its peers, Vascular Biogenics Ltd. has a significantly lower P/E ratio than Equillium, Inc. at -5.5396 and OncoCyte Corp. at -2.9218, both of which are also categorized as risky. The company's returns have been dismal, with a year-to-date decline of -99.64% compared to a 12.22% gain in the S&P 500, reinforcing the notion that it is not a viable investment at this time...."
      }
    ],
    "total": 6,
    "sid": "1125499",
    "stock_news_url": "https://www.marketsmojo.com/news/vascular-biogenics-1125499"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Vascular Biogenics Ltd. technically bullish or bearish?

2025-09-20 19:41:51

As of 16 December 2024, the technical trend for Vascular Biogenics Ltd. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD also shows mild bullishness. However, the daily moving averages are mildly bearish, and the KST is bearish on both weekly and monthly time frames. The Bollinger Bands are sideways weekly but mildly bearish monthly, and there is no trend indicated by Dow Theory or OBV. The company has significantly underperformed compared to the S&P 500, with a year-to-date return of -99.64% versus the S&P 500's 12.22%, and a one-year return of -99.98% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bearish, driven by mixed signals across various indicators....

Is Vascular Biogenics Ltd. overvalued or undervalued?

2025-09-20 18:16:59

As of 28 March 2019, the valuation grade for Vascular Biogenics Ltd. moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company appears to be overvalued given its current financial metrics, including a P/E ratio of -0.0001 and an EV to EBITDA of 0.28, which are both indicative of severe financial distress. Additionally, the negative ROE of -170.61% further underscores the challenges the company faces. In comparison to its peers, Vascular Biogenics Ltd. has a significantly lower P/E ratio than Equillium, Inc. at -5.5396 and OncoCyte Corp. at -2.9218, both of which are also categorized as risky. The company's returns have been dismal, with a year-to-date decline of -99.64% compared to a 12.22% gain in the S&P 500, reinforcing the notion that it is not a viable investment at this time....

View All News